Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

An injectable ibuprofen gel speeds up diabetic wound healing by reducing inflammation and promoting tissue growth.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Adapalene 0.1% effectively reduces acne by decreasing comedones and altering skin properties.

Apremilast helps regrow hair in hard-to-treat alopecia areata.